Document Detail


First trimester medical termination of pregnancy: an alternative for New Zealand women.
MedLine Citation:
PMID:  16704471     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: First trimester medical terminations of pregnancy (TOP) have been carried out in a private abortion clinic in Auckland from 1 July 2003 to 30 June 2005. AIMS: To audit first trimester medical TOP outcomes over the first 2 years and to compare the demographics and complication rates of women opting for medical TOP with those choosing surgical TOP during this period. METHODS: Retrospective, consecutive case audit of women presenting for a first trimester TOP. Anonymous audit included ethnicity, gestation at first appointment, pain relief requirements, blood loss, timing from the taking of misoprostol to expulsion of products of conception, complications and comparison of outcomes and characteristics between medical termination of pregnancy (MTOP) and surgical termination of pregnancy (STOP). RESULTS: A total of 3311 TOPs were performed over the 2-year study period, including 390 MTOPs (12%). No significant differences were found in age, ethnicity or history of previous TOP between women choosing MTOP or STOP. Gravida 1 and nulliparous women were significantly more likely to choose MTOP. Five per cent (21/390) of women taking mifepristone progressed to STOP. Complications involving hospitalisation occurred in six MTOPs (1.5%) and 18 STOPs (0.6%). CONCLUSIONS: First trimester MTOP is safe and effective and is a realistic alternative for women wanting choice of method in New Zealand.
Authors:
Felicity Goodyear-Smith; Alison Knowles; Jonathan Masters
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Australian & New Zealand journal of obstetrics & gynaecology     Volume:  46     ISSN:  0004-8666     ISO Abbreviation:  Aust N Z J Obstet Gynaecol     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-05-17     Completed Date:  2006-08-09     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0001027     Medline TA:  Aust N Z J Obstet Gynaecol     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  193-8     Citation Subset:  IM    
Affiliation:
Auckland Medical Aid Centre, Mt. Eden, Auckland, New Zealand. f.goodyear-smith@auckland.ac.nz
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents / administration & dosage
Abortion, Induced / adverse effects,  methods*,  utilization
Adolescent
Adult
Ambulatory Care Facilities / standards
Child
Female
Humans
Medical Audit*
Medical Records
Mifepristone / administration & dosage
New Zealand / epidemiology
Outcome Assessment (Health Care)*
Postoperative Complications
Pregnancy
Pregnancy Trimester, First
Retrospective Studies
Chemical
Reg. No./Substance:
0/Abortifacient Agents; 84371-65-3/Mifepristone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Preterm outcome table (POT): a simple tool to aid counselling parents of very preterm infants.
Next Document:  Compliance with a risk factor-based intrapartum prophylaxis program for neonatal group B streptococc...